Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.
暂无分享,去创建一个
Qian Tao | Hao Sun | Yuan Zhang | Xianwei Su | Y. Zhang | F. Chan | Q. Tao | S. Tsao | K. Sun | Y. Zeng | Lili Li | A. Chan | Hao Sun | Kun Sun | Anthony T C Chan | Lili Li | Yichao Fan | Yi-Xin Zeng | Sai Wah Tsao | T. Loh | Zhenfang Du | Thomas K S Loh | Wai Yee Chan | Francis Kl Chan | X. Su | Yichao Fan | Z. Du | W. Chan
[1] D. Kwong,et al. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting , 2015, International journal of cancer.
[2] Lanlan Shen,et al. Targeted p16(Ink4a) epimutation causes tumorigenesis and reduces survival in mice. , 2014, The Journal of clinical investigation.
[3] S. Ogawa,et al. The genomic landscape of nasopharyngeal carcinoma , 2014, Nature Genetics.
[4] F. Yang,et al. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth , 2014, Oncogene.
[5] K. Yao,et al. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker. , 2014, Oncology reports.
[6] R. Irizarry,et al. Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population , 2014, Epigenetics.
[7] Gianluca Bontempi,et al. A comprehensive overview of Infinium HumanMethylation450 data processing , 2013, Briefings Bioinform..
[8] X. Guan,et al. Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma , 2013, International journal of cancer.
[9] Song Zhang,et al. Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma , 2013, Cancer Cell International.
[10] Jun Yu,et al. The Metalloprotease ADAMTS8 Displays Antitumor Properties through Antagonizing EGFR–MEK–ERK Signaling and Is Silenced in Carcinomas by CpG Methylation , 2013, Molecular Cancer Research.
[11] Q. Tao,et al. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. , 2013, Carcinogenesis.
[12] Q. Tao,et al. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells , 2013, Journal of cellular and molecular medicine.
[13] J. Sung,et al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer , 2013, Oncogene.
[14] Brandilyn A. Peters,et al. Batch Effects and Pathway Analysis: Two Potential Perils in Cancer Studies Involving DNA Methylation Array Analysis , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[15] G. Lang,et al. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. , 2013, Carcinogenesis.
[16] R. Weksberg,et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.
[17] Cancer research in an era when epigenetics is no longer “epi”—challenges and opportunities , 2013, Chinese journal of cancer.
[18] Q. Tao,et al. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas , 2013, Cellular and Molecular Life Sciences.
[19] Q. Tao,et al. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer , 2013, Breast Cancer Research.
[20] Xiuqing Zhang,et al. Double restriction-enzyme digestion improves the coverage and accuracy of genome-wide CpG methylation profiling by reduced representation bisulfite sequencing , 2013, BMC Genomics.
[21] G. Ren,et al. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[22] Zhe Zhang,et al. Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma. , 2012, Cancer letters.
[23] J. Inazawa,et al. Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma. , 2012, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] R. Ben Gacem,et al. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[25] W. Jia,et al. Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma. , 2012, Seminars in cancer biology.
[26] K. To,et al. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. , 2012, Seminars in cancer biology.
[27] Yuan Zhang,et al. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas , 2011, Oncogene.
[28] E. Zabarovsky,et al. Tumor suppressor dual‐specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial‐mesenchymal transition (EMT)‐associated phenotype , 2012, International journal of cancer.
[29] Q. Tao,et al. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins , 2012, BMC Cancer.
[30] H. Aburatani,et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. , 2011, Cancer research.
[31] Zhe Zhang,et al. CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. , 2011, Cancer Letters.
[32] Q. Tao,et al. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors , 2011, Oncogene.
[33] Q. Tao,et al. Epigenetic disruption of cell signaling in nasopharyngeal carcinoma , 2011, Chinese journal of cancer.
[34] N Clarke,et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma , 2011, Oncogene.
[35] J. Califano,et al. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma , 2011, International journal of cancer.
[36] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[37] Jaap M Middeldorp,et al. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population , 2011, Molecular Cancer.
[38] Arvindhan G. Nagarajan,et al. Advances in genome-wide DNA methylation analysis. , 2010, BioTechniques.
[39] Andrew P. Feinberg,et al. Epigenomics Reveals a Functional Genome Anatomy and a New Approach to Common Disease , 2010, Nature Biotechnology.
[40] T. Fukagawa,et al. KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. , 2010, Cancer research.
[41] E. Liu,et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci , 2010, Nature Genetics.
[42] W. Jia,et al. The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma , 2010, Clinical Cancer Research.
[43] O. Rennert,et al. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer , 2010, British Journal of Cancer.
[44] Ngan-Ming Tsang,et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. , 2009, American journal of human genetics.
[45] Wei Zheng,et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. , 2009, Cancer research.
[46] E. Liu,et al. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. , 2008, Cancer research.
[47] M. Lung,et al. Epigenetic disruption of interferon-γ response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas , 2008, Oncogene.
[48] A. Cheung,et al. Expression of concern: Characterization of a novel epigenetically‐silenced, growth‐suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma , 2008, International journal of cancer.
[49] R. Durbin,et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis , 2008, Nature Biotechnology.
[50] Qiang Yu,et al. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. , 2008, Cancer cell.
[51] A. Mutirangura,et al. Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma. , 2008, Oral oncology.
[52] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[53] Zhong-ying Shen,et al. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas , 2007, Oncogene.
[54] Jun Yu,et al. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer , 2007, British Journal of Cancer.
[55] Zhong-ying Shen,et al. Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers , 2007, Proceedings of the National Academy of Sciences.
[56] G. Srivastava,et al. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas , 2007, Laboratory Investigation.
[57] Q. Tao,et al. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments , 2007, Expert Reviews in Molecular Medicine.
[58] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[59] J. Califano,et al. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation , 2007, Oncogene.
[60] P. Meltzer,et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase , 2006, International journal of cancer.
[61] Q. Tao,et al. Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. , 2006, Frontiers in bioscience : a journal and virtual library.
[62] H. Fujii,et al. CpG Island M`ethylation Status in Gastric Carcinoma with and without Infection of Epstein-Barr Virus , 2006, Clinical Cancer Research.
[63] T. Putti,et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation , 2006, Oncogene.
[64] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[65] Q. Tao,et al. Frequent Hypermethylation of RASSF1A, TSLC1, High Viral Load of Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma, Matched Tumor-Adjacent Tissues , 2005 .
[66] H. Cheung,et al. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation , 2005, Molecular carcinogenesis.
[67] W. Lam,et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.
[68] Q. Tao,et al. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. , 2005, Neoplasia.
[69] E. Liu,et al. Fine mapping of the 11q22–23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma , 2004, International journal of cancer.
[70] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[71] Qian Tao,et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma , 2004, Oncogene.
[72] Kwok Wai Lo,et al. Focus on nasopharyngeal carcinoma. , 2004, Cancer cell.
[73] A. Hui,et al. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma , 2003, Molecular carcinogenesis.
[74] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[75] D. Kwong,et al. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[76] D. Kwong,et al. Differential gene methylation in undifferentiated nasopharyngeal carcinoma. , 2003, International journal of oncology.
[77] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[78] N. Raab-Traub. Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.
[79] Q. Tao,et al. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. , 2002, Human molecular genetics.
[80] Yan Fang,et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4 , 2002, Nature Genetics.
[81] S. Tsao,et al. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. , 2002, Biochimica et biophysica acta.
[82] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[83] M. Rhyu,et al. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. , 2002, The American journal of pathology.
[84] P. Johnson,et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[85] J. Kwong,et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. , 2001, Cancer research.
[86] N. Raab-Traub,et al. Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma , 2000, International journal of cancer.
[87] A. Wolffe,et al. Epigenetics: regulation through repression. , 1999, Science.
[88] S. Cheung,et al. Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virus , 1999, International journal of cancer.
[89] Q. Tao,et al. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. , 1999, The American journal of pathology.
[90] S. Leung,et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. , 1996, Cancer research.
[91] E. Kieff. Epstein-Barr virus and its replication , 1996 .
[92] M. Lipinski,et al. Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas , 1988, International journal of cancer.
[93] H. Maruyama,et al. Functional , 2020, Congress of Neurological Surgeons Essent.